Elisa Fabbrini, VP, Clinical Development
Professional Overview
Elisa Fabbrini is an accomplished clinical development executive with extensive experience in the pharmaceutical and biotechnology industries. As the Vice President of Clinical Development at MBX Biosciences, Inc., she oversees the strategic planning and execution of complex clinical trials, driving the advancement of innovative therapeutics. Elisa's expertise spans translational and experimental medicine, with a proven track record of leading cross-functional teams to achieve critical milestones and deliver meaningful clinical outcomes.
Experience Summary
Current Role
As the Vice President of Clinical Development at MBX Biosciences, Inc., Elisa is responsible for the overall strategy, planning, and implementation of the company's clinical development programs. She leads a team of clinical professionals in the design and execution of high-impact studies, ensuring the seamless progression of drug candidates through the development pipeline. Elisa's strategic vision and hands-on approach have been instrumental in accelerating the progress of MBX Biosciences' portfolio, positively impacting patient outcomes.
Career Progression
Prior to her current role, Elisa served as the Senior Director of Translational and Experimental Medicine at Johnson & Johnson Innovative Medicine, where she spearheaded the advancement of early-stage therapeutic candidates through proof-of-concept studies. She previously held the position of Director of Clinical Development at The Janssen Pharmaceutical Companies of Johnson & Johnson, where she played a pivotal role in the successful completion of multiple clinical trials. Elisa's academic background includes an appointment as an Assistant Professor at the Washington University School of Medicine, where she contributed to cutting-edge research and the mentorship of the next generation of clinical researchers.
Academic Background
Elisa Fabbrini holds a Ph.D. in Biomedical Sciences from a prestigious research institution, with a specialization in translational medicine and clinical pharmacology. Her academic achievements include numerous peer-reviewed publications and invited presentations at leading industry conferences, showcasing her dedication to advancing the field of clinical development.
Areas of Expertise
- Clinical trial design and execution
- Translational and experimental medicine
- Cross-functional team leadership
- Regulatory strategy and compliance
- Biomarker identification and validation
- Innovative data analysis and interpretation
Professional Impact
Throughout her career, Elisa has made significant contributions to the pharmaceutical and biotechnology industries. Her leadership in the design and implementation of groundbreaking clinical trials has led to the successful advancement of multiple drug candidates, positively impacting patient populations. Elisa's collaborative approach and commitment to excellence have earned her recognition as a respected clinical development expert, driving meaningful progress in the industry.
Conclusion
Elisa Fabbrini's wealth of experience and proven expertise in clinical development position her as a valuable asset to MBX Biosciences, Inc. and the broader pharmaceutical industry. Her strategic vision, technical competence, and track record of successful project delivery make her a strategic partner in the quest to bring transformative therapies to patients in need.
